Wagner v. Ohio State University Medical Center

934 N.E.2d 394, 188 Ohio App. 3d 65
CourtOhio Court of Appeals
DecidedJune 8, 2010
DocketNo. 09AP-1031
StatusPublished
Cited by11 cases

This text of 934 N.E.2d 394 (Wagner v. Ohio State University Medical Center) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wagner v. Ohio State University Medical Center, 934 N.E.2d 394, 188 Ohio App. 3d 65 (Ohio Ct. App. 2010).

Opinion

Tyack, Presiding Judge.

{¶ 1} Plaintiff-appellant John T. Wagner brought a negligence action in the Court of Claims of Ohio against defendant-appellee the Ohio State University Medical Center (“OSU”). OSU moved for summary judgment, and after briefing, the trial court heard oral argument. The Court of Claims granted summary judgment in favor of OSU, and Wagner appealed.

{¶ 2} Because this is an appeal from a summary judgment, our review is de novo, and we construe the following facts in the light most favorable to Wagner. Grafton v. Ohio Edison Co. (1996), 77 Ohio St.3d 102, 105, 671 N.E.2d 241; Civ.R. 56(C).

{¶ 3} Wagner suffers from chronic pancreatitis, a condition that causes him extreme pain. Wagner first met Dr. G. Todd Schulte when he was in his residency at the OSU Pain Clinic. In January 2000, Schulte, an anesthesiologist, surgically implanted a morphine pump into Wagner. The pump relieved Wagner’s unrelenting pain, and his quality of life improved dramatically.

{¶ 4} In 2002, OSU hired Schulte as a physician and as a faculty member/researcher. During his entire employment with OSU, Schulte was a chemically impaired physician practicing under a consent agreement with the State of Ohio Medical Board.

{¶ 5} Wagner continued to treat with Schulte at the OSU Pain Clinic. In early 2002, Schulte and Wagner discussed Schulte’s desire to do research into what Schulte called “pain markers,” and Schulte suggested that Wagner could be a [68]*68participant in the research. Wagner was willing to do so in order to benefit others in chronic pain.

{¶ 6} Wagner developed a “father-son” type of relationship with Schulte. In addition, Wagner also developed a close relationship with OSU Pain Clinic staff, physicians, and other patients. Wagner was asked by Schulte and other OSU physicians to counsel fellow pain-clinic patients on dealing with their morphine pumps and other pain treatments. Wagner wrote proposals for an OSU Pain Patient Support Group, which he was to head. OSU Pain Clinic personnel were well aware of the close relationship between Wagner and Schulte.

{¶ 7} In July 2004, Wagner accompanied Schulte to a meeting with Dr. Michael B. Howie, Chair of OSU’s Department of Anesthesia, and Schulte’s chairman and ultimate supervisor. Wagner was there to lend support for Schulte’s problem in obtaining renewal of malpractice insurance: a problem that Schulte attributed to a conflict with another physician. Schulte appeared very sleepy at that meeting, but Dr. Howie never suggested then or at any later time to Wagner that Schulte was an impaired physician due to drugs. Much later, Schulte admitted that he had access to his mother’s morphine after she died and that he had taken her morphine that day.

{¶ 8} Schulte had several conversations with Dr. Howie and other OSU physicians concerning his impairment or appearance of impairment. A patient complained that he thought Schulte had taken his Dilaudid on one occasion. Schulte was asked to provide a urine sample, and the sample was negative. Schulte later admitted that the doctor who was monitoring Schulte’s urine tests would sit at a desk and fill out paperwork while Schulte went into the bathroom to provide the sample. Schulte substituted concealed clean urine in place of his own urine. This led to his testing negative for drugs at that time, although he later tested positive for morphine on September 24, 2004.

{¶ 9} Schulte testified by way of deposition that he had been sent home from work on several occasions by Dr. Severyn, who made the determination that Schulte was not fit to treat patients at the OSU Pain Clinic on those days. A registered nurse wrote a memo to Dr. Severyn in early July 2004. The memo detailed an incident in which it appeared that Schulte had removed 3 ml. of Dilaudid from a syringe used during a pump-refill procedure. In August and September 2004, several nurses and Dr. Severyn made written reports about Schulte’s condition. Schulte’s lethargy, slurred speech, somnolence, rambling and inconsistent statements, and inability to function are well documented in those letters and memoranda.

{¶ 10} Eventually, in September 2004, OSU removed Schulte from patient care at the Pain Clinic and placed him on administrative leave. Schulte was referred for evaluation to the Cleveland Clinic in-patient program on October 4, 2004.

[69]*69{¶ 11} On November 12, 2004, the Medical Board suspended Schulte’s license to practice medicine for an indefinite period of not less than one year. OSU then revoked Schulte’s clinical and hospital privileges and terminated his contract as a clinical physician. OSU did not communicate any of this information to Wagner. On November 15, Wagner was seen at the OSU Pain Clinic by another physician who was not his usual treating physician. When asked, that physician told Wagner that she did not know where Schulte was.

{¶ 12} OSU retained Schulte in his paid faculty/researcher position until January 21, 2005. OSU asserts that this was to allow Schulte to retain his health insurance. He kept his pager, ID badges, and computer password, which gave him access to OSU facilities, equipment, and computers.

{¶ 13} On December 12, 2004, Schulte wrote to Department Chair Dr. Howie, asking for the opportunity to do medical research within the department of anesthesiology. Schulte also had an in-person conversation with Dr. Howie in December 2004 in which Dr. Howie approved of Schulte’s continuing with ongoing research. OSU takes the position that Schulte never had permission to conduct any research after his license was revoked, and there were no ongoing research projects available to him.

{¶ 14} On January 3, 2005, Dr. Severyn wrote a memo detailing an incident in which a nurse discovered that Schulte had withdrawn Dilaudid from the pain pump of an OSU patient, Tom Schulte, Schulte’s father. Additionally, Dr. Severyn discovered that Schulte possessed a pump-programming unit and that he had been manipulating the dosage of pain medication that his father received. None of this information was conveyed to Wagner, who had a similar father-son type of relationship with Schulte.

{¶ 15} On January 12, 2005, Schulte telephoned Wagner to ask whether he could withdraw a spinal-fluid sample from his pain pump as part of Schulte’s research into pain markers. Wagner agreed, and Schulte went to Wagner’s home dressed in OSU scrubs and carrying a medical kit. Instead of withdrawing a spinal-fluid sample, Schulte used a needle and syringe to withdraw the morphine from Wagner’s pump. Schulte then used the morphine to feed his own drug habit.

{¶ 16} Within a matter of eight hours, Wagner began to experience pain like that of a pancreatitis attack. He was admitted to the hospital, but his pain was not under control when he was discharged.

{¶ 17} Six days after Schulte took Wagner’s morphine from his pump, Schulte went to the home of another trusting patient, Jesse Persinger, where he again siphoned morphine from the patient’s pain pump.

[70]*70{¶ 18} On January 24, 2005, Wagner’s home nurse arrived for a regularly scheduled appointment to refill his pain pump. She withdrew an orange colored fluid from the pump and replaced it with morphine. She asked Wagner whether he had seen Schulte recently, and Wagner replied that he had. The nurse notified OSU and had him report to the hospital. Wagner remained hospitalized until February 7, 2005.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wilkes v. Ohio Dept. of Transp.
2024 Ohio 558 (Ohio Court of Claims, 2024)
Meolatate v. Ohio State Univ.
2023 Ohio 3805 (Ohio Court of Appeals, 2023)
Thomas v. LSREF3 Bravo (Ohio), L.L.C.
2022 Ohio 4476 (Ohio Court of Appeals, 2022)
A.M. v. Miami Univ.
2017 Ohio 8586 (Ohio Court of Appeals, 2017)
Emahiser v. Complete Coverage Insurance, LLP
53 F. Supp. 3d 1025 (N.D. Ohio, 2014)
Jackson v. Hogeback
2014 Ohio 2578 (Ohio Court of Appeals, 2014)
Chapa v. Genpak, L.L.C.
2014 Ohio 897 (Ohio Court of Appeals, 2014)
Base-Smith v. Lautrec, Ltd.
2014 Ohio 349 (Ohio Court of Appeals, 2014)
Lindsay P. v. Towne Properties Asset Mgt. Co., Ltd.
2013 Ohio 4124 (Ohio Court of Appeals, 2013)
Brown-Spurgeon v. Paul Davis Systems of Tri-State Area, Inc.
2013 Ohio 1845 (Ohio Court of Appeals, 2013)
Wagner v. Ohio State Univ. Med. Ctr.
2012 Ohio 3853 (Ohio Court of Claims, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
934 N.E.2d 394, 188 Ohio App. 3d 65, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wagner-v-ohio-state-university-medical-center-ohioctapp-2010.